Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome
CSBabyBiome
Timing of Umbilical Cord Clamping During an Elective Caesarean Delivery and Its Association With Neonatal Gut Microbiome.
3 other identifiers
interventional
33
1 country
1
Brief Summary
In this study, investigators seek to determine whether the timing of antibiotics given to mothers during an elective C-section affects the composition of their infant's gut microbiome. To do this, a randomized controlled trial (RCT) was carried out with women undergoing elective C-sections. These women were either given antibiotics before the skin incision (AB+) or after the umbilical cord was clamped (AB-).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 25, 2023
CompletedFirst Posted
Study publicly available on registry
September 11, 2023
CompletedSeptember 13, 2023
September 1, 2023
3.6 years
August 25, 2023
September 11, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Infant microbial species level differences between two groups
Centered log ratio transformed relative abundance differences of bacterial species (relative abundance of \> 0.05% and present in at least 2 infants) between two interventional groups
First 6 weeks of life
Infant Alpha Diversity differences between two groups
Alpha Diversity difference measured by the Shannon Diversity Index of infant microbiome at species level between two interventional groups
First 6 weeks of life
Infant Beta Diversity differences between two groups
Beta Diversity difference in Aitchison distances between the two intervention groups
First 6 weeks of life
Infant Antibiotic Resistance total gene load differences between two groups
Infant Antibiotic Resistance total gene load differenced measured in RPKM between the two interventional groups
First 6 weeks of life
Secondary Outcomes (1)
Number of participants with post c-section maternal wound infection
First 6 weeks of life
Study Arms (2)
Cord clamped after antibiotic prophylaxis
ACTIVE COMPARATORUmbilical cord clamped after 1g of cephazolin
Cord clamped before antibiotic prophylaxis
EXPERIMENTALUmbilical cord clamped before 1g of cephazolin
Interventions
Cord clamping before or after antibiotic (cefazolin) prophylaxis
Eligibility Criteria
You may qualify if:
- Females undergoing elective CS at the UMCG
- Gestational age in weeks equal to or above 38 weeks
You may not qualify if:
- Cephalosporin allergy
- Exposure to antibiotic agent 2 weeks before CS
- Temperature \>37.5 C before CS
- Pre-labour rupture of membranes
- Emergency CS
- No -20 freezer at home
- No command of the Dutch language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Groningen
Groningen, 9713 GZ, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Trishla Sinha, MD
University Medical Center Groningen
- PRINCIPAL INVESTIGATOR
Alexandra Zhernakova, MD/PhD
University Medical Center Groningen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2023
First Posted
September 11, 2023
Study Start
March 1, 2019
Primary Completion
October 1, 2022
Study Completion
March 1, 2023
Last Updated
September 13, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Data will become available upon publication
- Access Criteria
- Must fill in the form that the data will be used for research purposes.
The sequencing data of the microbiome will be available for other researchers via EGA